These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 36930965

  • 1. Natural History of Anemia and Efficacy and Safety of Oral Iron Therapy in Children Newly Diagnosed With Inflammatory Bowel Disease.
    D'Arcangelo G, Distante M, Veraldi S, Tarani F, Musto F, Aloi M.
    J Pediatr Gastroenterol Nutr; 2023 Jun 01; 76(6):771-775. PubMed ID: 36930965
    [Abstract] [Full Text] [Related]

  • 2. Pediatric Crohn's disease, iron deficiency anemia and intravenous iron treatment: a follow-up study.
    Valério de Azevedo S, Maltez C, Lopes AI.
    Scand J Gastroenterol; 2017 Jan 01; 52(1):29-33. PubMed ID: 27576956
    [Abstract] [Full Text] [Related]

  • 3. Safety and Efficacy of Ferric Carboxymaltose in the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease, in Routine Daily Practice.
    Stein J, Aksan A, Klemm W, Nip K, Weber-Mangal S, Dignass A.
    J Crohns Colitis; 2018 Jun 28; 12(7):826-834. PubMed ID: 29955835
    [Abstract] [Full Text] [Related]

  • 4. Inflammatory bowel disease and anemia: intravenous iron treatment.
    Kangaspunta M, Haapamäki J, Färkkilä M, Arkkila P.
    Scand J Gastroenterol; 2018 Apr 28; 53(4):430-434. PubMed ID: 29468908
    [Abstract] [Full Text] [Related]

  • 5. Safety and efficacy of sucrosomial iron in inflammatory bowel disease patients with iron deficiency anemia.
    Abbati G, Incerti F, Boarini C, Pileri F, Bocchi D, Ventura P, Buzzetti E, Pietrangelo A.
    Intern Emerg Med; 2019 Apr 28; 14(3):423-431. PubMed ID: 30499070
    [Abstract] [Full Text] [Related]

  • 6. Safety and efficacy of parenteral iron in children with inflammatory bowel disease.
    Papadopoulos M, Patel D, Korologou-Linden R, Goto E, Soondrum K, Fell JME, Epstein J.
    Br J Clin Pharmacol; 2018 Apr 28; 84(4):694-699. PubMed ID: 29266387
    [Abstract] [Full Text] [Related]

  • 7. Treatment with Noripurum EV® is effective and safe in pediatric patients with inflammatory bowel disease and iron deficiency anemia.
    Venturieri MO, Komati JTS, Lopes LHC, Sdepanian VL.
    Scand J Gastroenterol; 2019 Feb 28; 54(2):198-204. PubMed ID: 30782036
    [Abstract] [Full Text] [Related]

  • 8. Ferric carboxymaltose treatment for iron deficiency anemia in children with inflammatory bowel disease: Efficacy and risk of hypophosphatemia.
    Cococcioni L, Pensabene L, El-Khouly S, Chadokufa S, McCartney S, Saliakellis E, Kiparissi F, Borrelli O.
    Dig Liver Dis; 2021 Jul 28; 53(7):830-834. PubMed ID: 33775573
    [Abstract] [Full Text] [Related]

  • 9. Ferric Carboxymaltose Versus Ferrous Fumarate in Anemic Children with Inflammatory Bowel Disease: The POPEYE Randomized Controlled Clinical Trial.
    Bevers N, Van de Vijver E, Aliu A, Rezazadeh Ardabili A, Rosias P, Stapelbroek J, Bertrams Maartens IA, van de Feen C, Escher H, Oudshoorn A, Teklenburg S, Vande Velde S, Winkens B, Raijmakers M, Vreugdenhil A, Pierik MJ, van Rheenen PF.
    J Pediatr; 2023 May 28; 256():113-119.e4. PubMed ID: 36563900
    [Abstract] [Full Text] [Related]

  • 10. Intravenous Iron Sucrose for Treatment of Iron Deficiency Anemia in Pediatric Inflammatory Bowel Disease.
    Stein RE, Plantz K, Maxwell EC, Mamula P, Baldassano RN.
    J Pediatr Gastroenterol Nutr; 2018 Feb 28; 66(2):e51-e55. PubMed ID: 28704225
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness and safety of ferric carboxymaltose treatment in children and adolescents with inflammatory bowel disease and other gastrointestinal diseases.
    Laass MW, Straub S, Chainey S, Virgin G, Cushway T.
    BMC Gastroenterol; 2014 Oct 17; 14():184. PubMed ID: 25326048
    [Abstract] [Full Text] [Related]

  • 12. Iron status and analysis of efficacy and safety of ferric carboxymaltose treatment in patients with inflammatory bowel disease.
    Beigel F, Löhr B, Laubender RP, Tillack C, Schnitzler F, Breiteneicher S, Weidinger M, Göke B, Seiderer J, Ochsenkühn T, Brand S.
    Digestion; 2012 Oct 17; 85(1):47-54. PubMed ID: 22179489
    [Abstract] [Full Text] [Related]

  • 13. Safety of ferric carboxymaltose immediately after infliximab administration, in a single session, in inflammatory bowel disease patients with iron deficiency: a pilot study.
    Cortes X, Borrás-Blasco J, Molés JR, Boscá M, Cortés E.
    PLoS One; 2015 Oct 17; 10(5):e0128156. PubMed ID: 26011514
    [Abstract] [Full Text] [Related]

  • 14. An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark.
    Pollock RF, Muduma G.
    Adv Ther; 2018 Dec 17; 35(12):2128-2137. PubMed ID: 30456520
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of iron deficiency anemia and iron deficiency in a pediatric population with inflammatory bowel disease.
    Carvalho FSG, de Medeiros IA, Antunes H.
    Scand J Gastroenterol; 2017 Oct 17; 52(10):1099-1103. PubMed ID: 28643539
    [Abstract] [Full Text] [Related]

  • 16. Rapid recurrence of IBD-associated anemia and iron deficiency after intravenous iron sucrose and erythropoietin treatment.
    Kulnigg S, Teischinger L, Dejaco C, Waldhör T, Gasche C.
    Am J Gastroenterol; 2009 Jun 17; 104(6):1460-7. PubMed ID: 19491860
    [Abstract] [Full Text] [Related]

  • 17. Safety and efficacy of intravenous iron isomaltoside for correction of anaemia in patients with inflammatory bowel disease in everyday clinical practice.
    Stein J, Walper A, Klemm W, Farrag K, Aksan A, Dignass A.
    Scand J Gastroenterol; 2018 Sep 17; 53(9):1059-1065. PubMed ID: 30222479
    [Abstract] [Full Text] [Related]

  • 18. Ferric carboxymaltose prevents recurrence of anemia in patients with inflammatory bowel disease.
    Evstatiev R, Alexeeva O, Bokemeyer B, Chopey I, Felder M, Gudehus M, Iqbal T, Khalif I, Marteau P, Stein J, Gasche C, FERGI Study Group.
    Clin Gastroenterol Hepatol; 2013 Mar 17; 11(3):269-77. PubMed ID: 23078888
    [Abstract] [Full Text] [Related]

  • 19. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study.
    Schröder O, Mickisch O, Seidler U, de Weerth A, Dignass AU, Herfarth H, Reinshagen M, Schreiber S, Junge U, Schrott M, Stein J.
    Am J Gastroenterol; 2005 Nov 17; 100(11):2503-9. PubMed ID: 16279906
    [Abstract] [Full Text] [Related]

  • 20. Anemia and iron deficiency in inflammatory bowel disease: an open, prospective, observational study on diagnosis, treatment with ferric carboxymaltose and quality of life.
    Befrits R, Wikman O, Blomquist L, Hjortswang H, Hammarlund P, Bajor A, Klintman D, Blom H.
    Scand J Gastroenterol; 2013 Sep 17; 48(9):1027-32. PubMed ID: 23889159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.